Healthcare | July 11, 2023
Bausch + Lomb acquires Blink eye drops
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
Global pharmaceutical company having a surgical business concept incepted in Dubai
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Results from year two of the pivotal Phase 3 KITE clinical trial reaffirmed visual acuity gains and fluid reduction findings as well as safety profile from year one
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
Subscribe To Our Newsletter & Stay Updated
